CCCC C4 Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $362.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $475.0K |
| 2022-Q2 | $84.0K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $31.7K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $3.7K |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $22.2K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $122.5K |
Bought$115.7K2 buy days
Sold$676.4K7 sell days
Net insider flow-$560.7Knet selling · 5 years
Latest trade2026-11-12Adams Kendra
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-12 | Sell | Adams Kendra | CFO | 45,173 | $2.71 | $122.5K | 1 |
| 2026-01-16 | Sell | REYNO LEONARD | Other C-suite | 10,000 | $2.22 | $22.2K | 1 |
| 2025-02-18 | Sell | Boyle Scott N | Other C-suite | 669 | $3.15 | $2.1K | 1 |
| 2025-02-14 | Sell | Boyle Scott N | Other C-suite | 490 | $3.15 | $1.5K | 1 |
| 2023-02-08 | Buy | Koppikar Utpal | Director | 5,667 | $5.60 | $31.7K | 1 |
| 2022-04-12 | Buy | Hirsch Andrew | CEO | 10,000 | $8.40 | $84.0K | 1 |
| 2022-01-04 | Sell | Crystal Adam | Other C-suite | 15,000 | $31.67 | $475.0K | 2 |
| 2021-12-17 | Sell | Salter Malcolm | Director | 755 | $30.25 | $22.8K | 1 |
| 2021-11-19 | Sell | Salter Malcolm | Director | 755 | $40.11 | $30.3K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Crystal Adam | Other C-suite | $0 | $475.0K | 2022-01-04 |
| Adams Kendra | CFO | $0 | $122.5K | 2026-11-12 |
| Hirsch Andrew | CEO | $84.0K | $0 | 2022-04-12 |
| Salter Malcolm | Director | $0 | $53.1K | 2021-12-17 |
| Koppikar Utpal | Director | $31.7K | $0 | 2023-02-08 |
| REYNO LEONARD | Other C-suite | $0 | $22.2K | 2026-01-16 |
| Boyle Scott N | Other C-suite | $0 | $3.7K | 2025-02-18 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2020-10-06 | 3 | $220.6K | 27 | -9.1% (-5.5% raw) | +12.7% (+25.3% raw) | -3.2% (+19.4% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.